iHealthScreen aims to develop novel, innovative software for retinal image grading and diagnosis of diseases and screen diseases - to detect at an early stage. We have software for vessel caliber and width measurement, retinal image calibration, retinal central light reflex quantification, focal arteriolar narrowing, and artery-vein nicking quantification, which are significant features for early detection of Diabetes, hypertension, and Cardiovascular Heart Disease (CVD) and Stroke. We aim to develop a system for early screening of Diabetic Retinopathy (DR) and Age-Related Macular Degeneration (AMD). Based on this work, we also aim to develop a prediction model for screening individuals at risk of systemic diseases such as Alzheimer’s disease (AD) and CVD. A retinal imaging-based system will screen these diseases from regular visits to Family Physician, Community Clinics, Optometrist, or Ophthalmologist. An integrated screening system will help prevent these diseases, improve the patient’s quality of life, and save billions of dollars in healthcare costs. Today, the telemedicine field is changing faster than ever before. Therefore, another aim is to develop a telemedicine platform. Telemedicine was initially intended to treat patients who were located in remote places, far away from health facilities, or in areas of shortages of medical professionals. Telemedicine is still used today to address these problems. It’s increasingly become a tool for convenient medical care. Today’s connected patient wants to waste less time in the waiting room, and get immediate care when they decide they want or need the care. Achievements of iHealthScreen.
Get the best experience with Kemon app!
